Free Trial

Nutriband (NTRB) to Release Earnings on Tuesday

Nutriband logo with Medical background

Nutriband (NASDAQ:NTRB - Get Free Report) will likely be posting its quarterly earnings results before the market opens on Tuesday, April 29th. Analysts expect Nutriband to post earnings of ($0.12) per share and revenue of $0.71 million for the quarter.

Nutriband Price Performance

Shares of NTRB remained flat at $5.32 on Friday. The stock had a trading volume of 8,835 shares, compared to its average volume of 75,047. The firm has a market capitalization of $59.08 million, a P/E ratio of -7.49 and a beta of 1.19. The company has a quick ratio of 4.83, a current ratio of 4.96 and a debt-to-equity ratio of 0.01. Nutriband has a fifty-two week low of $3.30 and a fifty-two week high of $11.78. The business has a fifty day moving average price of $6.08 and a 200 day moving average price of $5.74.

Analyst Ratings Changes

Separately, Noble Financial started coverage on shares of Nutriband in a research report on Wednesday, January 22nd. They issued an "outperform" rating and a $13.00 price objective for the company.

Get Our Latest Stock Report on Nutriband

About Nutriband

(Get Free Report)

Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy.

See Also

Earnings History for Nutriband (NASDAQ:NTRB)

Should You Invest $1,000 in Nutriband Right Now?

Before you consider Nutriband, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutriband wasn't on the list.

While Nutriband currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines